0001140361-18-011724.txt : 20180302
0001140361-18-011724.hdr.sgml : 20180302
20180302172329
ACCESSION NUMBER: 0001140361-18-011724
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170628
FILED AS OF DATE: 20180302
DATE AS OF CHANGE: 20180302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FILDES FRANCIS
CENTRAL INDEX KEY: 0001661786
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 18663398
MAIL ADDRESS:
STREET 1: 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2017-06-28
2017-06-30
0
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001661786
FILDES FRANCIS
BLOCK 10-1, BLANCHARDSTOWN
CORPORATE PARK, BALLYCOOLIN
DUBLIN
L2
15
IRELAND
1
0
0
0
Stock Option (right to buy)
10.51
2017-06-28
4
A
0
35000
10.51
A
2018-06-28
2022-06-28
ADSs
35000
35000
D
Options become exercisable as to all 35,000 ADSs on the first anniversary of the 06/28/2017 grant date.
The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
This amendment to the Form 4 filed by the reporting person on June 30, 2017 (the "Previous Form 4") is being filed solely to correct the number of derivative securities acquired and the number of derivative securities beneficially owned following the transaction reported in Columns 5 and 9 of Table II of the Previous Form 4. The number of derivative securities in the Previous Form 4 was incorrectly listed as 30,000 and has been corrected to 35,000.
/s/ Phillandas T. Thompson, as attorney-in-fact for Francis Fildes
2018-03-02